STOCK-BASED COMPENSATION PLANS (Tables)

9 Months Ended

Sep. 30, 2024

STOCK-BASED COMPENSATION PLANS

Schedule of outstanding and exercisable number of options

	Outstanding Number of Options	Exercisable Number of Options
	(in thousands)	(in thousands)
Plan Category
2005 Stock Option Plan	1	1
2017 Stock Option Plan	338	338
Total	339	339

Schedule of stock-based compensation expenses recorded in the condensed consolidated statements of operations

The following summarizes stock-based compensation expenses recorded in the condensed consolidated statements of income (in thousands):

	For the Three Months Ended September 30,				For the Nine Months Ended September 30,
	2024		2023		2024		2023
Cost of Revenue	$	10	$	10	$	27	$	26
Sales and marketing expense		125		53		492		182
General, and administrative		635		591		1,826		1,413
Total stock-based compensation expense	$	770	$	654	$	2,345	$	1,621

Schedule of stock option activity under all equity compensation plans

				Weighted-
		Weighted-		Average	Aggregate
	Number of	Average		Remaining	Intrinsic
	Shares	Exercise		Contractual	Value
	(in thousands)	Price		Term (Years)	(in thousands)
Outstanding at December 31, 2023	349	$	1.82	4.12	$	3,163
Granted	—		—	—		—
Forfeited	(3)		3.14	—		—
Exercised	(7)		2.46	—		—
Outstanding and exercisable at September 30, 2024	339	$	1.79	3.38	$	2,156

Schedule of restricted stock award activity under all equity compensation plans

	Number of
	Shares	Weighted Average
	(in thousands)	Grant Date Fair Value
Outstanding at December 31, 2023	502	$	10.73
Granted	229		10.66
Forfeited	(14)		10.03
Vested	(209)		11.37
Outstanding at September 30, 2024	508	$	10.46